Abbott to hike production of lower-cost glucose monitors as diabetes soars

54

Abbott Laboratories plans to ramp up manufacturing capacity for its lower-cost continuous glucose monitor, the FreeStyle Libre, by three to five times in the next few years, aiming to reach millions more patients worldwide, the company told Reuters.

http://feeds.reuters.com/~r/reuters/healthNews/~3/JheSky_-bWM/abbott-to-hike-production-of-lower-cost-glucose-monitors-as-diabetes-soars-idUSKCN1UB0Z3